Over the last decade, there have been numerous developments and changes in treatment
practices for the management of patients with immune thrombocytopenia (ITP). This article is …

Primary immune thrombocytopenia (ITP) is an immune-mediated bleeding disorder
characterized by decreased platelet counts and an increased risk of bleeding. Multiple …

Reports of ChAdOx1 vaccine–associated thrombocytopenia and vascular adverse events
have led to some countries restricting its use. Using a national prospective cohort, we …

Immune thrombocytopenia (ITP) is the most common acquired thrombocytopenia after
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …

Immune thrombocytopenia (ITP) is now well‐known to reduce patients' health‐related
quality of life. However, data describing which signs and symptoms patients and physicians …

Immune thrombocytopenia (ITP) is an autoimmune disorder defined by a significantly
reduced number of platelets in blood circulation. Due to low levels of platelets, ITP is …

Platelet autoantibody (PA) testing has previously shown poor sensitivity for immune
thrombocytopenia (ITP) diagnosis, but no previous study used both 2011 American Society …

Essentials• The diagnosis of ITP is based on a platelet count< 100× 10 9 L− 1 and exclusion
of other causes.• There are no standard tests or biomarkers to diagnose ITP.• The sensitivity …

COVID-19 vaccination and immune thrombocytopenia | Nature Medicine Skip to main content
Thank you for visiting nature.com. You are using a browser version with limited support for …

Introduction Primary immune thrombocytopenia (ITP) is an autoimmune disorder
characterized by a low platelet count (< 100× 109/L) with an increased risk of bleeding …